Michigan Youth Violence Prevention Center: Building Evidence for Gun Violence Prevention - SafERteens Implementation
3 other identifiers
interventional
171
1 country
6
Brief Summary
The purpose of this study is to determine the preliminary efficacy (via a micro-randomized trial \[MRT\] design) of augmenting Enhanced-Replicating Effective Program (E-REP) with engagement strategies to increase and sustain reach by healthcare providers (e.g., nurses, social workers) during implementation of the SafERteens program across multiple healthcare settings.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2023
Typical duration for not_applicable
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 28, 2023
CompletedFirst Submitted
Initial submission to the registry
April 6, 2023
CompletedFirst Posted
Study publicly available on registry
April 20, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 13, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 13, 2026
CompletedApril 29, 2026
April 1, 2026
3.1 years
April 6, 2023
April 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Preliminary Efficacy: weekly reach by providers
Reach is defined as the number of participants screened or the number of participants to whom the intervention was delivered. The researchers hypothesize that during weeks where providers receive an engagement strategy (ES), reach will be higher than weeks where no ES is received.
From the start of implementation to 52 weeks or the end of provider's employment if before 52 weeks.
Preliminary Efficacy: monthly reach by providers
Reach is defined as the number of participants screened or the number of participants to whom the intervention was delivered. The researchers hypothesize that during months where providers receive personalized feedback, reach will be higher than months where no ES is received.
From the start of implementation to 52 weeks or the end of provider's employment if before 52 weeks.
Study Arms (6)
Narrative Persuasion (randomized weekly, 1 of 4 options)
EXPERIMENTALNarrative persuasion will be youth or provider testimonial about violence in their community and/or how SafERteens helped their development and reduced violence. Randomized weekly.
Reciprocity (randomized weekly, 1 of 4 options)
EXPERIMENTALThe reciprocity engagement strategy (ES) will be operationalized as an unsolicited $5 gift card with the SafERteens Logo. Randomized weekly.
Commitment (randomized weekly, 1 of 4 options)
EXPERIMENTALCommitment will be operationalized as a pledge committing to screening and/or delivering SafERteens (depending on role). Randomized weekly.
Engagement Strategy Control (randomized weekly, 1 of 4 options)
NO INTERVENTIONThe control condition will involve no ES for the weekly Engagement Strategies. Randomized weekly.
Personalized feedback control (randomized monthly, 1 of 2 options)
NO INTERVENTIONThe control condition will involve no personalized feedback. Randomized monthly
Personalized feedback (randomized monthly, 1 of 2 options)
EXPERIMENTALThe feedback ES will be operationalized as a visual graphic of their personal performance screening and/or delivering SafERteens in relation to the mean of the provider group and/or towards a pre-set standard (i.e., screening 75% of adolescents; delivery rate of 75% of eligible youth). Personalized feedback or none will be randomized on a monthly basis.
Interventions
Narratives will use anonymous testimonials from our prior work combined with open-source pictures. The researchers will ask participants to rate the testimonial message as a measure of engagement.
Researchers will track clicking on the gift card as a measure of engagement
Researchers will track clicking on a link and/or opening to review visual data as a source of engagement.
Providers will receive a commitment message and be asked to reply as a measure of engagement.
Eligibility Criteria
You may qualify if:
- Employed at study site
- Participate in screening and/or SafERteens delivery.
You may not qualify if:
- Would not be expected to complete screening and/or intervention delivery
- Would not begin screening and/or delivering SafERteens within the first 9 months of cohort implementation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Michiganlead
- Centers for Disease Control and Preventioncollaborator
Study Sites (6)
University of Michigan
Ann Arbor, Michigan, 48109, United States
Trinity Health Medical Group, Academic Family Medicine - Fruitport
Fruitport, Michigan, 49415, United States
Muskegon Pediatrics
Muskegon, Michigan, 49440, United States
HealthWest Youth and Family Services
Muskegon, Michigan, 49442, United States
Trinity Health - Community Health And Well-Being
Muskegon, Michigan, 49444, United States
Trinity Health-Emergency Department
Muskegon, Michigan, 49444, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Patrick Carter, MD
University of Michigan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, University of Michigan Institute for Firearm Injury Prevention Associate Professor, Department of Emergency Medicine
Study Record Dates
First Submitted
April 6, 2023
First Posted
April 20, 2023
Study Start
February 28, 2023
Primary Completion
April 13, 2026
Study Completion
April 13, 2026
Last Updated
April 29, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share